Philadelphia, PA, United States of America

Aaron D Gitler

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Foster City, CA (US) (2014 - 2019)
  • Philadelphia, PA (US) (2013 - 2020)

Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: **Inventor Spotlight: Aaron D. Gitler**

Introduction

Aaron D. Gitler, an innovative inventor based in Philadelphia, PA, has made significant contributions to the field of biomedical research. With a total of 12 patents to his name, he focuses on advancing our understanding of neurodegenerative diseases and cellular mechanisms.

Latest Patents

Gitler's recent work includes several cutting-edge patents. One of his latest patents is centered on "Modulators of Alpha-Synuclein Toxicity". This patent discloses compositions and methods aimed at modulating the expression of genes involved in ER to Golgi trafficking. The compounds derived from this research may inhibit the toxicity associated with alpha-synuclein, providing potential treatments for synucleinopathies such as Parkinson's disease. Another significant patent relates to "Yeast Cells Expressing TAR DNA-Binding Protein 43". This patent outlines methods for screening yeast cells to discover compounds that can prevent or suppress TDP-43-induced toxicity, thereby holding promise for addressing diseases like frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Career Highlights

Throughout his career, Gitler has held influential positions at prominent organizations. He has worked at the Whitehead Institute for Biomedical Research, contributing to groundbreaking research that impacts neuroscience. Additionally, he has collaborated with The Curators of the University of Missouri, further enriching his experience in the biomedical field.

Collaborations

Gitler has collaborated with notable colleagues, including Susan L. Lindquist. These partnerships have played a crucial role in his research endeavors, fostering environments where innovative ideas can flourish and lead to new discoveries.

Conclusion

Aaron D. Gitler's contributions to innovation in biomedical research are invaluable. With a focus on therapies for neurodegenerative diseases and a robust portfolio of patents, his work continues to inspire advancements in the field. As he progresses in his career, Gitler remains a pivotal figure in the quest for solutions to complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…